AI-generated summary
The authors studied zinc phthalocyanine combined with low-level laser irradiation in the ZR-75-1 human breast cancer cell line grown in vitro. They report reduced cell viability, increased apoptosis and necrosis, lower migration and MMP-9 activity, and reduced GALNT11 levels and Bcl-2 expression with increased Bax. The authors suggest the approach could be an alternative breast cancer treatment, but this is a laboratory cell study.
- Who or what was studied
- Human breast cancer ZR-75-1 cell line (in vitro cells, not patients)
- Limits stated in the abstract
- The study uses cultured cells only, so the findings do not establish effects in humans or in living tissue.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 70 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.